Archive Category: Green Zone Fortunes Updates

In this week’s video, I spotlight one of our “Imperium” stocks: immuno-pharma company AIM ImmunoTech Inc. (NYSE: AIM). A microcap stock, AIM is a speculative play, so please don’t bet the farm. However, in today’s update, I explain the multiple paths to success and profitability that I’ve identified for AIM.

In the July edition of our portfolio update, I revisit buy-up-to prices on three of our high-performing stocks.

After Hurricane Irma drove torrential rains into my wife’s Toyota RAV4 in 2017, we considered upgrading to an electric vehicle (EV).

This week, Adam O’Dell is putting the finishing touches on the July issue of Green Zone Fortunes. Keep an eye out on Friday. We’re buying an innovative tech company that I guarantee you’ve heard of — but you’ve likely never thought of it as such. Stay tuned!

I’m convinced that we’re witnessing the start of a market boom that will surpass any we’ve seen before … one that will mint more new millionaires in the next 12 months than in the last 15 years.